INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the FirmBusiness Wire • 08/04/22
DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 08/04/22
VRCA LAWSUIT ALERT: Levi & Korsinsky Notifies Verrica Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlinePRNewsWire • 08/04/22
Verrica Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before August 5, 2022 to Discuss Your Rights - VRCANewsfile Corp • 08/04/22
FRIDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 08/03/22
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the FirmBusiness Wire • 08/03/22
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Verrica Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 5, 2022 - (NASDAQ: VRCA)PRNewsWire • 08/03/22
VRCA Investors Have Opportunity to Lead Verrica Pharmaceuticals Inc. Securities Fraud LawsuitPRNewsWire • 08/02/22
FRIDAY DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 08/02/22
VRCA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 5, 2022 in the Class Action Filed on Behalf of Verrica Pharmaceuticals, Inc. ShareholdersPRNewsWire • 08/02/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verrica Pharmaceuticals, Inc. -VRCAPRNewsWire • 08/01/22
Verrica Pharmaceuticals Announces Start of Phase 3 Trial of VP-102 for the Treatment of Molluscum Contagiosum by Torii Pharmaceutical Co., Ltd. in JapanGlobeNewsWire • 08/01/22
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Verrica Investors of a Lead Plaintiff Deadline of August 5, 2022PRNewsWire • 08/01/22
VRCA INVESTOR NOTICE: ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Verrica Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important August 5 Deadline in Securities Class Action - VRCAPRNewsWire • 07/31/22
ROSEN, Leading Investor Counsel, Encourages Verrica Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important August 5 Deadline in Securities Class Action - VRCANewsfile Corp • 07/29/22
Verrica Class Action: Levi & Korsinsky Reminds Verrica Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 5, 2022 - VRCANewsfile Corp • 07/28/22
ROSEN, National Trial Lawyers, Encourages Verrica Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important August 5 Deadline in Securities Class Action - VRCANewsfile Corp • 07/28/22
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 07/25/22
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Verrica Pharmaceuticals Inc. Investors With Losses to Secure Counsel Before Important August 5 Deadline in Securities Class Action - VRCANewsfile Corp • 07/24/22
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Verrica Pharmaceuticals Inc. Investors to Secure Counsel Before Important August 5 Deadline in Securities Class Action - VRCAPRNewsWire • 07/23/22
VRCA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 5, 2022 in the Class Action Filed on Behalf of Verrica Pharmaceuticals, Inc. Limited ShareholdersNewsfile Corp • 07/22/22
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 07/22/22
ROSEN, National Trial Lawyers, Encourages Verrica Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - VRCANewsfile Corp • 07/20/22
Berger Montague Investigates Securities Fraud Allegations Against Verrica Pharmaceuticals, Inc. (NASDAQ: VRCA) - VERRICA PHARMACEUTICALS, INC. - Lead Plaintiff Deadline is August 5, 2022PRNewsWire • 07/20/22
Verrica Pharmaceuticals Inc. (VRCA) Upgraded to Strong Buy: What Does It Mean for the Stock?Zacks Investment Research • 07/20/22
